Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lewis A Grossman

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Yale Journal of Health Policy, Law, and Ethics|July 3, 2013
The origins of American health libertarianismLewis A Grossman
American Journal of Law & Medicine|November 1, 2017
AIDS Activists, FDA Regulation, and the Amendment of America's Drug ConstitutionLewis A Grossman
The New England Journal of Medicine|September 19, 2022
Pushing Back with Pills - Enhancing Access to Reproductive Health Drugs after <i>Dobbs</i>Lewis A Grossman
Cornell Law Review|July 16, 2008
Food, drugs, and droods: a historical consideration of definitions and categories in American food and drug lawLewis A Grossman
JAMA|October 27, 2025
State Mifepristone Regulation Following GenBioPro v RaynesGreer Donley, Lewis A Grossman, Patricia J Zettler
The New England Journal of Medicine|January 7, 2026
Using FDA Law to Threaten Medical PracticeLewis A Grossman, Nathan G Cortez, Patricia J Zettler
Science (New York, N.Y.)|April 27, 2023
Pressing regulatory challenges for psychedelic medicineAmy L McGuire, Holly Fernandez Lynch, Lewis A Grossman, et al.
Annals of Internal Medicine|November 6, 2023
The Mifepristone Litigation: Untangling the Implications of the Fifth Circuit's Decision for Abortion Access and the U.S. Food and Drug AdministrationPatricia J Zettler, Lewis A Grossman, Eli Y Adashi, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Yale Journal of Health Policy, Law, and Ethics|July 3, 2013
The origins of American health libertarianismLewis A Grossman
American Journal of Law & Medicine|November 1, 2017
AIDS Activists, FDA Regulation, and the Amendment of America's Drug ConstitutionLewis A Grossman
The New England Journal of Medicine|September 19, 2022
Pushing Back with Pills - Enhancing Access to Reproductive Health Drugs after <i>Dobbs</i>Lewis A Grossman
Cornell Law Review|July 16, 2008
Food, drugs, and droods: a historical consideration of definitions and categories in American food and drug lawLewis A Grossman
JAMA|October 27, 2025
State Mifepristone Regulation Following GenBioPro v RaynesGreer Donley, Lewis A Grossman, Patricia J Zettler
The New England Journal of Medicine|January 7, 2026
Using FDA Law to Threaten Medical PracticeLewis A Grossman, Nathan G Cortez, Patricia J Zettler
Science (New York, N.Y.)|April 27, 2023
Pressing regulatory challenges for psychedelic medicineAmy L McGuire, Holly Fernandez Lynch, Lewis A Grossman, et al.
Annals of Internal Medicine|November 6, 2023
The Mifepristone Litigation: Untangling the Implications of the Fifth Circuit's Decision for Abortion Access and the U.S. Food and Drug AdministrationPatricia J Zettler, Lewis A Grossman, Eli Y Adashi, et al.
Pageof 1